Stay updated on Pembrolizumab with CyBorD in NDMM Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with CyBorD in NDMM Clinical Trial page.

Latest updates to the Pembrolizumab with CyBorD in NDMM Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA new site revision, v3.3.4, was added to the release notes, replacing the previous revision v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedIn the Record History, a new entry 'Revision: v3.3.3' was added, and the items 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed. These updates relate to site/version metadata rather than the study content.SummaryDifference0.2%

- Check52 days agoChange DetectedThe history now includes Revision: v3.3.2 and removes Revision: v3.3.1 from the list.SummaryDifference0.1%

- Check59 days agoChange DetectedRecord History now includes a new revision entry v3.3.1 and removes v3.2.0.SummaryDifference0.1%

- Check67 days agoChange DetectedRemoved the general site-wide notice about a lapse in government funding and operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check81 days agoChange DetectedThe changes are limited to the record history entries (new version dates and notes) and do not alter core trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab with CyBorD in NDMM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with CyBorD in NDMM Clinical Trial page.